BHI News Section

Riley-Brown will succeed Kurt Newman, M.D., who has served in role for over 11 years

March 23, 2023

The Children’s National Board of Directors announced today that Michelle Riley-Brown, MHA, FACHE, has been named as the new president and chief executive officer (CEO) of Children’s National Hospital. On July 1, Riley-Brown will succeed Kurt Newman, M.D., who is retiring after 11 years as president and CEO.

Riley-Brown is an accomplished executive with over 20 years of experience leading and supporting children’s healthcare. She is currently an executive vice president at Texas Children’s Hospital at the Texas Medical Center in Houston, where she serves concurrently as the president of two hospitals in the system while leading the construction and staffing of a third. She also leads system-level operations, strategic planning, physician practice acquisition, quality performance, clinical operations, fund development, marketing, brand management and public relations for the nation’s largest pediatric and women’s healthcare organization.

At Johnson & Johnson Innovation – JLABS, part of our mission is to bring big company benefits to entrepreneurs and startups, along with our network. We also know that networks really do matter when it comes to access to capital.

In leaning into our mission, on March 9th, we brought together more than 30 startup companies and 30 investors from across the US and Canada to JLABS @ Washington, DC for our second annual Johnson & Johnson Innovation – JLABS East North America Investor & Partnering Event.

Leiden, March 3, 2023 – MIMETAS has achieved major milestones in its partnership with Roche, developing models for Inflammatory Bowel Disease (IBD) and Hepatitis B Virus infections (HBV).

In July 2021, MIMETAS and Roche entered a risk-sharing collaboration to develop human disease models for the characterization of novel compounds in Inflammatory Bowel Disease (IBD) and Hepatitis B virus infections (HBV). You can find the original press release here.

Image: https://www.mimetas.com

March 22, 2023 – The BioHealth Capital Region (BHCR) with The District of Columbia, Maryland, and Virginia are making a name for themselves as some of the most innovative states in the nation, according to a new study by WalletHub. All three have secured spots in the Top 10 of WalletHub’s 2022 rankings of the Most Innovative States. This recognition highlights the region’s strength as a hub for innovation and technological advancement.

The study compared all 50 states and the District of Columbia across 24 key indicators of innovation-friendliness, including research and development spending per capita, the share of STEM professionals, and tech company density. The District of Columbia took the top spot overall, with Maryland coming in at number 5 and Virginia rounding out the top 10 at number 9. These strong rankings reflect the region’s commitment to fostering a culture of innovation and investing in developing cutting-edge technologies.

In a long-awaited decision, the National Institutes of Health rejected a petition urging the agency to use a controversial provision of federal law to widen access to a cancer drug by forcing the manufacturers to license their patents.

GAITHERSBURG, MD / ACCESSWIRE / February 16, 2023 / BullFrog AI Holdings, Inc. (NASDAQ:BFRG; BFRGW) (“Bullfrog AI” or the “Company”), a digital technology company using machine learning to usher in a new era of precision medicine, announced today the closing of its initial public offering of 1,297,318 units (each, a “Unit,” collectively, the “Units”) at a price of $6.50 per unit for a total of approximately $8.4 million of gross proceeds to the Company. Each Unit consists of one share of the Company’s common stock, one tradeable warrant (each, a “Tradeable Warrant,” collectively, the “Tradeable Warrants”) to purchase one share of common stock at an exercise price of $7.80 per share, and one non-tradeable warrant (each, a “Non-tradeable Warrant,” collectively, the “Non-tradeable Warrants”; together with the Tradeable Warrants, each, a “Warrant,” collectively, the “Warrants”) to purchase one share of the Company’s common stock at an exercise price of $8.125.

Hot off the press: TSESSEBE Technologies Won $5,000 at the #NCBCP Black Women’s Roundtable event. Our sincere appreciation to #bwrsummit23 leadership and The Coca-Cola Company for investing this seed award in us this #womenshistorymonth! #TSESSEBETech is taking it to the TOP leveraging technology to empower, liberate, and revolutionize the personalized health landscape and the health data ownership paradigm. First stop, #ooTANOBC for Breast Cancer Health, and soon breaking ground in other diseases and spheres of life REIMAGINing paradigm and practice as we ACT! Dee C. Marshall, Tameka M. Ramsey, MPA, BSW, Melanie Campbell, Tonya Tyson – we couldn’t have done it without you, THANK YOU. For my SiStars and our Women around the world, we remain undaunted! #technology #innovation #leadership #breastcancer #health #healthequity

Advanced Research Projects Agency for Health (ARPA-H) has recently opened its first Agency-wide Open Broad Agency Announcement (BAA), which seeks funding proposals for research to improve health outcomes across patient populations, communities, diseases, and health conditions. The BAA calls for proposals that outline breakthrough research and technological advancements, investigate unconventional approaches, and challenge accepted assumptions to enable leaps forward in science, technology, systems, or related capabilities. ARPA-H also encourages concepts that advance the objectives of President Biden’s Cancer Moonshot initiative, as well as more disease-agnostic approaches.​

Join us for a lunch and learn to hear how new technologies in quantum computing will be utilized to power scientific research and the life science companies already taking advantage. Shahar Keinan, CEO, and Maurice Benson, Lead Software Engineer at POLARISqb, will give a presentation on how the innovations in the quantum computing industry will directly impact the future of drug design, clinical research, and precision medicine. POLARISqb has created one of the first platforms for the life sciences industry that can cut the drug discovery research process timeline from its traditional time of 5 years down to 4 months. Shahar and Maurice will also discuss how quantum computers are beginning to be made ready for commercial use and all of the recent case studies on their performance.

Image: https://www.eventbrite.com